Back to search

Article

Recent advances in (therapeutic protein) drug development

2017-02-07

Abstract excerpt

Therapeutic protein drugs are an important class of medicines serving patients most in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, autoimmunity/inflammation, exposure to infectious agents, and genetic disorders. The latest advances in protein-engineering technologies have allowed drug developers...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a25f565f-e1f5-56b1-a0aa-c384e72e2b27
DOI
10.12688/f1000research.9970.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Recent advances in (therapeutic protein) drug developmentDOI 10.12688/f1000research.9970.1
Development of therapeutic proteins: advances and challengesSemantic proximity
Protein therapeutics: promises and challenges for the 21st centurySemantic proximity
Pharmaceutical and industrial protein engineering: where we are?Semantic proximity
Machine-guided dual-objective protein engineering for deimmunization and therapeutic functionsSemantic proximity
Recombinant proteins for therapySemantic proximity
Beyond antibodies: using biological principles to guide the development of next-generation protein therapeuticsSemantic proximity
Host cell proteins in biologics development: Identification, quantitation and risk assessmentSemantic proximity
Integrating Computational Design and Experimental Approaches for Next-Generation BiologicsSemantic proximity
DARPins: A new generation of protein therapeuticsSemantic proximity
Modular Protein Engineering in Emerging Cancer TherapiesSemantic proximity
Affordable mRNA Novel Proteins, Recombinant Protein Conversions and “Biosimilars”—Advice to Developers and Regulatory AgenciesSemantic proximity
Protein engineering approaches for antibody fragments: directed evolution and rational design approachesSemantic proximity
Select a neighboring publication to make it the new centre.